Investigating THSD4 as a novel mediator of breast cancer immunosuppression and pembrolizumab resistance

The Operating Grants Program is the principal means by which the Cancer Research Society (CRS) fulfills its mission to support fundamental, early translational and environment-cancer research on all types of cancer to contribute to the advancement of science aimed at preventing, detecting and treating this disease.